PCOS linked to higher risk of adverse birth outcomes

FHS
July 5, 2024
11:01 am

The association between polycystic ovary syndrome (PCOS) and birth outcomes in women.

CPSI Rebrands as TruBridge

What You Should Know: – CPSI (NASDAQ: CPSI) announced a strategic rebranding, transitioning to TruBridge, Inc. (“TruBridge”) effective March 4, 2024. – The rebrand reflects

February 23, 2024

Xlife Sciences AG Expands Collaboration with Department of Health Abu Dhabi, Partners with Thermo Fisher Scientific and Masdar City – Biotech Investments

Xlife Sciences AG / Key word(s): Alliance/Letter of Intent Xlife Sciences AG Expands Collaboration with Department of Health Abu Dhabi, Partners with Thermo Fisher Scientific

February 6, 2024

Telix announces Canada approval for Illuccix label expansion

Illuccix is used for PET imaging to detect PSMA-positive lesions in male prostate cancer patients. Credit: Korawat photo shoot/Shutterstock. Health Canada has expanded the approved

October 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.